Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma

References

• Kim HJ, Czischke K, Brennan MF, Conlon KC. Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer?. J Gastrointest Surg 2002; 6: 763–9
   PubMed Web of Science ®Google Scholar
• Karmazanovsky G, Fedorov V, Kubyshkin V, Kotchatkov A. Pancreatic head cancer: Accuracy of CT in determination of resectability. Abdom Imaging 2005; 30: 488–500
   PubMedGoogle Scholar
• House MG, Yeo CJ, Cameron JL, Campbell KA, Schulick RD, Leach SD, et al. Predicting resectability of periampullary cancer with three-dimensional computed tomography. J Gastrointest Surg 2004; 8: 280–8
   PubMed Web of Science ®Google Scholar
• Vargas R, Nino-Murcia M, Trueblood W, Jeffrey RB, Jr. MDCT in Pancreatic adenocarcinoma: Prediction of vascular invasion and resectability using a multiphasic technique with curved planar reformations. AJR Am J Roentgenol 2004; 182: 419–25
   PubMed Web of Science ®Google Scholar
• Valls C, Andia E, Sanchez A, Fabregat J, Pozuelo O, Quintero JC, et al. Dual-phase helical CT of pancreatic adenocarcinoma: Assessment of resectability before surgery. AJR Am J Roentgenol 2002; 178: 821–6
   PubMed Web of Science ®Google Scholar
• McCarthy MJ, Evans J, Sagar G, Neoptolemos JP. Prediction of resectability of pancreatic malignancy by computed tomography. Br J Surg 1998; 85: 320–5
   PubMed Web of Science ®Google Scholar
• Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004; 350: 1200–10
   PubMed Web of Science ®Google Scholar
• Klinkenbijl JH, Jeekel J, Sahmoud T, van Pel R, Couvreur ML, Veenhof CH, et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 1999;230:776–82; discussion 82–4.
   PubMed Web of Science ®Google Scholar
• Kalser MH, Ellenberg SS. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985; 120: 899–903
   PubMed Web of Science ®Google Scholar
• Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 1987;59:2006–10.
   PubMed Web of Science ®Google Scholar
• Chauffert B, Mornex F, Bonnetain F, Triboulet J, Bouche O, Rougier P, et al. Phase III trial comparing initial chemoradiotherapy (intermittent cisplatin and infusional 5-FU) followed by gemcitabine vs. gemcitabine alone in patients with locally advanced non metastatic pancreatic cancer: A FFCD-SFRO study. J Clin Oncol 2006; 24: 180s, (Abstr:4008)
   Web of Science ®Google Scholar
• Krempien R, Muenter MW, Harms W, Debus J. Neoadjuvant chemoradiation in patients with pancreatic adenocarcinoma. HPB 2006; 8: 22–8
   PubMedGoogle Scholar
• Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: Pathology, complications, and outcomes. Ann Surg 1997;226:248–57; discussion 57–60.
   PubMed Web of Science ®Google Scholar
• Jones L, Russell C, Mosca F, Boggi U, Sutton R, Slavin J, et al. Standard Kausch-Whipple pancreatoduodenectomy. Dig Surg 1999; 16: 297–304
   PubMed Web of Science ®Google Scholar
• Pedrazzoli S, Beger HG, Obertop H, Andren-Sandberg A, Fernandez-Cruz L, Henne-Bruns D, et al. A surgical and pathological based classification of resective treatment of pancreatic cancer. Summary of an international workshop on surgical procedures in pancreatic cancer. Dig Surg 1999; 16: 337–45
   PubMedGoogle Scholar
• Cancer Therapy Evaluation Program. Common toxicity criteria, Version 2.0 DCTD, NCI, DHHS. Accessable at: http://ctep.cancer.gov.
   Google Scholar
• Wanebo HJ, Glicksman AS, Vezeridis MP, Clark J, Tibbetts L, Koness RJ, et al. Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer. Arch Surg 2000;135:81–7; Discussion 8.
   PubMed Web of Science ®Google Scholar
• Snady H, Bruckner H, Cooperman A, Paradiso J, Kiefer L. Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial. Cancer 2000; 89: 314–27
   PubMed Web of Science ®Google Scholar
• White RR, Hurwitz HI, Morse MA, Lee C, Anscher MS, Paulson EK, et al. Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas. Ann Surg Oncol 2001; 8: 758–65
   PubMed Web of Science ®Google Scholar
• Mehta VK, Fisher G, Ford JA, Poen JC, Vierra MA, Oberhelman H, et al. Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas. J Gastrointest Surg 2001; 5: 27–35
   PubMed Web of Science ®Google Scholar
• Wilkowski R, Thoma M, Heinemann V, Rau HG, Wagner A, Stoffregen C, et al. Radiochemotherapy with gemcitabine and cisplatin in pancreatic cancer – feasible and effective. Strahlenther Onkol 2003; 179: 78–86
   PubMed Web of Science ®Google Scholar
• Magnin V, Moutardier V, Giovannini MH, Lelong B, Giovannini M, Viret F, et al. Neoadjuvant preoperative chemoradiation in patients with pancreatic cancer. Int J Radiat Oncol Biol Phys 2003; 55: 1300–4
   PubMed Web of Science ®Google Scholar
• Aristu J, Canon R, Pardo F, Martinez-Monge R, Martin-Algarra S, Manuel Ordonez J, et al. Surgical resection after preoperative chemoradiotherapy benefits selected patients with unresectable pancreatic cancer. Am J Clin Oncol 2003; 26: 30–6
   PubMed Web of Science ®Google Scholar
• Calvo FA, Matute R, Garcia-Sabrido JL, Gomez-Espi M, Martinez NE, Lozano MA, et al. Neoadjuvant chemoradiation with tegafur in cancer of the pancreas: Initial analysis of clinical tolerance and outcome. Am J Clin Oncol 2004; 27: 343–9
   PubMed Web of Science ®Google Scholar
• Joensuu TK, Kiviluoto T, Karkkainen P, Vento P, Kivisaari L, Tenhunen M, et al. Phase I–II trial of twice-weekly gemcitabine and concomitant irradiation in patients undergoing pancreaticoduodenectomy with extended lymphadenectomy for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 2004; 60: 444–52
   PubMed Web of Science ®Google Scholar
• Schmidt CM, Powell ES, Yiannoutsos CT, Howard TJ, Wiebke EA, Wiesenauer CA, et al. Pancreaticoduodenectomy: A 20-year experience in 516 patients. Arch Surg 2004;139:718–25; Discussion 25–7.
   PubMed Web of Science ®Google Scholar
• Trede M, Richter A, Wendl K. Personal observations, opinions, and approaches to cancer of the pancreas and the periampullary area. Surg Clin North Am 2001; 81: 595–610
   PubMed Web of Science ®Google Scholar
• Shinchi H, Takao S, Noma H, Matsuo Y, Mataki Y, Mori S, et al. Length and quality of survival after external-beam radiotherapy with concurrent continuous 5-fluorouracil infusion for locally unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 2002; 53: 146–50
   PubMed Web of Science ®Google Scholar
• Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial. JAMA 2007; 297: 267–77
   PubMed Web of Science ®Google Scholar